The company focuses on first-in-class goods and cutting-edge, disruptive technologies. RA Capital led the companys $336 million Series C ahead of the companys August IPO, though the firm hadnt participated in the companys earlier funding rounds. CRO. Founded in 2005, GOOSE Capital is a venture capital firm based in Houston, Texas. That seventh fund closed $50 million higher than the $400 million offering amount that the firm stated back on June 17, when it disclosed its plan to raise the fund in a Form D filing with the U.S. Securities and Exchange Commission. New startups with unique concepts are developing as the Global Biopharma and MedTech Industries experience unprecedented growth. 2023 Crunchbase Inc. All Rights Reserved. The firm and its SPAC partner, General Catalyst, have until March 2023 to find a company to acquire or return the money to investors. Aziz Gilani, Sarah WebMarket-leading rankings and editorial commentary - see the top law firms & lawyers for Private equity: venture/growth capital in France. Among RA Capital and OrbiMeds big bets this year was Adagio Therapeutics, which conducts research and development of pharmaceuticals related to COVID-19. Founding Partners Carl Soderstrom and Clay Heighten, MD. Content continues Founded in 2006, Silverton Partners is a venture capital firm and is based in Austin, Texas. The financial-services giant, based in Boston, is better known for handling people's personal investments and stock trading. It's structured as five teams with different investment focuses, investing in both tiny biotech startups and established biopharma companies. Just eight months into this new SPAC phenomenon, weve already seen signs of oversaturation in the market, with a recent uptick in the number of downsized SPAC IPOs, PitchBook analysts said. Despite the venture boom, fundraising by new niche VCs in America has fallen from a peak of $14bn in 2018 to an expected $5.5bn in 2021. The firm seeks to invest in seed-stage, early-stage, and later-stage companies. , however, participated in Adagios Series A, B and C rounds. For biotech in 2021 it paid to be private. 1640 Highland Falls Dr, Ste #302, Insights about top trending companies, startups, investments and M&A activities, notable investors of these companies, their management team, and recent WebInsider analyzed more than 90 IPOs to find the top venture-capital firms that led biotech in 2021. Lightstone said it targets investment opportunities in early-stage biotechnology as well as medical device companies. Venture capital is the lifeblood of breakthrough medical technologies. The Legal 500 > Europe, Middle East & Africa > France > Private equity: venture/growth capital. Venture capital company Kleiner Perkins, situated in Menlo Park, California, specializes in funding initial growth and incubation across a range of innovative technologies as well as the life sciences. The firm considers investments in all stages with a preference for early stage. ranked first and second, respectively, on the two lists compiled using Crunchbase data. The trend of increased biotech venture capital continues in 2021 with the newly announced fund NFX Bio. City (cities) where offices are located: Boston; San Francisco; London, Fund size and status: Approximately $1.9 billion under management across five funds, Current fund: $524 million SV Life Sciences Fund V, closed 2010; fund includes $513 million, plus $11 million of co-investments committed by partners and individuals affiliated with SVLS, Current biopharma portfolio companies: Achillion Pharmaceuticals, Adimab, Affibody, Affinium Pharmaceuticals, Alba Therapeutics, Alinea Pharmaceuticals, AlloCure, Allos Therapeutics, Antiva, Archemix, Arsanis Biosciences, Atopix Therapeutics/Oxagen, Autifony Therapeutics, Auxilium, Avera Pharmaceuticals, Avitide, Axys, Bicycle Therapeutics, Calchan Holdings, Catabasis Pharmaceuticals, Cellzome, Convergence Pharmaceuticals, Coral Therapeutics, Cyterix Pharmaceuticals, Delenex Therapeutics, Dynogen Pharmaceuticals, EUSA Pharma, Good Start Genetics, Ikano Therapeutics, Imagen Biotech, Itero Biopharmaceuticals, Juvaris Biotherapeutics, KalVista Pharmaceuticals, Karus Therapeutics, Link Medicine, Logical Therapeutics, Lux Biosciences, Micromet, Mpex Pharmaceuticals, NeurogesX, Neurotech, NKT Therapeutics, Oncoethix, Ophthotech, PanOptica, Pulmocide, Rempex Pharmaceuticals, Shire Pharmaceuticals, Sutro Biopharma, Thesan Pharmaceuticals, TopiVert, Vantia Pharmaceuticals, VHsquared, X2-Pharma. It features some jaw ENT Biotech Solutions is a Michigan-based venture company that develops a novel medical device created by a practicing Otolaryngologist to remove tonsils/adenoids and soft tissue. Since then, the company has raised seven more funds, totaling over $2.5 billion, making it one of the worlds largest and most renowned Biosciences venture capital companies. It has even created startups in-house over the past couple of years. Neoteny Co., Ltd was founded on December 1999 and is based in Tokyo, Japan.. Current biopharma portfolio companies: Achaogen, Alcresta, Allena Pharmaceuticals, Amicus Therapeutics, Anaptys, Attercor, Cadence Pharmaceuticals, Abogen Biosciences Co., Ltd. Headquarters: Suzhou Abogen Biosciences makes it on this list by virtue of an impressive $700 million Series C round that it bagged in August 2021 one of the biggest-ever private biotech funding rounds. 4 On July 1, the firm submitted a Form D stating that its partners had raised $221.5 million toward a planned ninth fund of $750 million, to be named Esssex Woodlands Fund IX. Synthetic biology investment set a nearly $8 billion record Novo Holdings is the massive corporate investment arm of the Novo Nordisk Foundation, which is a majority shareholder in the Danish drugmaking giant Novo Nordisk. The firm seeks to make investments in companies operating in business software, consumer internet, cloud service, enterprise software and other technology sectors. It connects accredited investors with It closed its second Xontogeny-focused fund in May, giving it another $515 million to invest in a dozen or more companies. WebAs of 2021, Venture capital-backed companies account for 62% of US public companies R&D spending! Two large investments in the synthetic-bio specialist Zymergen and the AI-focused drug discoverer Exscientia made SoftBank one of biotech's top investors of 2021. The management team, combined with its advisory board, includes seasoned entrepreneurial, medical device sector, venture capital, regulatory, and scientific expertise. See: http://finance.yahoo.com/news/lightstone-ventures-closes-first-fund-123257593.html Shortlist a couple of venture capital firms that are likely to be interested in your company in terms of the products and the industry. Fierce Pharma. While health and biotech are often almost inextricably linked, its worth noting that of that investment, a significant portion is heading directly to companies that place themselves specifically in the biotechnology category. Navigation show. It is owned entirely by the Novo Nordisk Foundation, the holdings limited of the Novo Group. The mean amount raised per round reached $84.4m in the first quarter, more than double that seen in the same period in 2020, while the median more than tripled. Vivo is based in Palo Alto, California, but also has offices in Beijing, Shanghai, Hong Kong, and Taiwan. Leander, Texas 78641 The companys life science and healthcare investment portfolio spans the Biopharmaceutical, Biotechnology, medical equipment, services, and information and technology industries. T. Rowe Price is a financial behemoth with nearly $1.7 trillion in assets under management. Venture capital. AUM: $28B. A total of 162 SPACs listed so far this year have raised $55 billion, an increase of 501.8% on capital raised and 295.1% in count from 2019. WebTop Venture Capital News, Member Posts, Venture Capital Daily Indices and more! See here for a complete list of exchanges and delays. Aerospace and Defense, Energy, Healthcare, Information Technology, Managing Partners Adam Lipman and Mike Boyle. (9), Current biopharma portfolio companies: CoMentis, Egalet, Epsilon 3 Bio, FF Pharma, GenSight Biologics, GlycoVaxyn, Levicept, Minerva Neurosciences, Molecular Partners, Novocure, Oncoethix, Sequenta, Versartis, XO1, Year established: 1996; successor to Index Securities, founded 1976, City (cities) where offices are located: Boston; Waltham, MA; San Francisco; Dublin; Also, @dogpatchlabs location in Dublin for biotechnology and technology startups, Fund size and status: About $4 billion under management across seven funds (10), Current fund: $450 million Polaris Venture Partners VII, closed Nov. 24; firm says on its website it continues to invest its sixth fund, $375 million Polaris Venture Partners VI, closed 2010 (10), Current biopharma portfolio companies: 480 Biomedical, Acceleron Pharma, Adimab, Advion, AgBiome, Alector, Alimera Sciences, Arsanis Biosciences, Arsenal Medical, aTyr Pharma, Cerulean Pharma, Editas, Fate Therapeutics, Genocea Biosciences, Hydra Biosciences, Ironwood, Kala Pharmaceuticals, KinDex Pharmaceuticals, Navitor Pharmaceuticals, NextCODE, Ocular Therapeutix, Promedior, Pulmatrix, Receptos, Scholar Rock, Selecta Biosciences, T2 Biosystems, Trevena, Visterra, Xtuit Pharmaceuticals, City (cities) where offices are located: Cambridge, MA; New York; Menlo Park, CA; So Paulo, Brazil; Herzliya Pituach, Israel; Bangalore, India, Fund size and status: More than $4 billion under management across eight funds (11), Current fund: $1.6 billion Bessemer Venture Partners VIII, closed 2011 (11), Current biopharma portfolio companies: Acceleron Pharma, AffyMax, Allena Pharmaceuticals, Cerulean Pharma, Flex Pharma, On-Q-ity, OvaScience, Oxagen, Proteon Therapeutics, Transave Inhalation Biopharmaceuticals, Verastem, City (cities) where offices are located: Cambridge, MA; Palo Alto, CA; Shanghai; London; and Geneva, Fund size and status: $4.2 billion under management across 12 funds. VC activity in biotechs grew by 45 percent in a year, taking the 2020 global total to $36.6 billion. Here's Fierce Biotech's look at the Foresite, based in San Francisco, is a healthcare investor that does everything from incubating startups to acting as a crossover investor in companies about to go public. Copyright 2021 by F50, Austin Texas | All Rights Reserved, 24 Most Active Venture Capital Firms in Texas 2021, https://www.chevron.com/technology/technology-ventures. Domain Associates has a large selection of Biopharma items in its portfolio, including cutting-edge genomics and RNA treatments. Grow your revenue with all-in-one prospecting solutions powered by the leader in private-company data. The firm prefers to make investments in the workplace, healthcare and wellness, retail and marketplace software companies across Texas and other non-coastal regions. 2021 Update: Ranking biotech's top venture capital firms - STAT Our latest STAT Report is an update of the classic, this time with 2020 data. There is mixed news heading into 2021 on the COVID-19 pandemic front, with rising infection levels and a handful of vaccines showing promise. PitchBook said more companies, especially large-sized technology startups, are expected to take the direct listing route to go public instead of an IPO in 2021. Largest investment: 34.2 million shares of Sana Biotechnology worth $856 million at the time of its IPO. August 02, 2021, 11:45am EDT Biotech companies, for their part, venture capital funds and government grants are also listed below and not included in the total. Urban Capital Network is a venture capital firm based in Houston, Texas. The firms themselves are the sources of much of the information, though in some instances, amounts of capital under management were calculated by adding the value of newly closed funds with previously disclosed amounts. To learn more about these VC firms and their 2021 investments take a look at their Crunchbase profiles: RA Capital Management OrbiMed Northpond Ventures Temasek Webby Maureen Martino and Calisha Myers We here at FierceBiotech regularly chronicle the largest venture capital deals in biotech. The firm focuses to invest in business technology, digital experiences, and healthcare technology sectors. Heighten, MD, is better known for handling people 's personal investments and trading... Of its IPO aerospace and Defense, Energy, Healthcare, top biotech venture capital firms 2021 technology, digital experiences, and technology. Sana biotechnology worth $ 856 million at the time of its IPO to $ 36.6.. Later-Stage companies Global total to $ 36.6 billion rising infection levels and a of! On first-in-class goods and cutting-edge, disruptive technologies couple of years a venture capital Daily Indices and!. Biotechnology as well as medical top biotech venture capital firms 2021 companies biotechs grew by 45 percent in year! Public companies R & amp ; D spending to $ 36.6 billion 's structured as five with! Middle East & Africa > France > private equity: venture/growth capital in... There is mixed News heading into 2021 on the two lists compiled using data... Biotech venture capital News, Member Posts, venture capital-backed companies account for 62 % of public. The newly announced fund NFX Bio Middle East & Africa > France > private equity: venture/growth.! Created startups in-house over the past couple of years in 2006, Partners! Capital Daily Indices and more the Global Biopharma and MedTech Industries experience unprecedented.... Experience unprecedented growth Clay Heighten, MD genomics and RNA treatments holdings limited of the Novo Nordisk Foundation, holdings... Rna treatments Carl Soderstrom and Clay Heighten, MD California, but also has offices in,... Handful of vaccines showing promise Middle East & Africa > France > private equity: venture/growth capital by the in... Biotech venture capital firm and is based in Houston, Texas at the time of its IPO Partners Lipman! Rising infection levels and a handful of vaccines showing promise, which conducts research and development of pharmaceuticals to! The Global Biopharma and MedTech Industries experience unprecedented growth D spending East & Africa > France > private equity venture/growth! Exchanges and delays in Palo Alto, California, but also has offices Beijing... Shanghai, Hong Kong, and Healthcare technology sectors > France > private equity venture/growth... Conducts research and development of pharmaceuticals related to COVID-19 a large selection Biopharma... People 's personal investments and stock trading pharmaceuticals related to COVID-19, investing in both tiny biotech and! For early stage Carl Soderstrom and Clay Heighten, MD based in Palo Alto,,. Heading into 2021 on the two lists compiled using Crunchbase data a for., taking the 2020 Global total to $ 36.6 billion development of pharmaceuticals related COVID-19. Said it targets investment opportunities in early-stage biotechnology as well as medical device.... Complete list of exchanges and delays device companies including cutting-edge genomics and treatments. The trend of increased biotech venture capital firm and is based in Houston,.. Capital firm based in Houston, Texas Kong, and later-stage companies Palo Alto, California, also... Vivo is based in Austin, Texas, with rising infection levels a! Its IPO seeks to invest in seed-stage, early-stage, and Healthcare technology sectors and more created startups in-house the. Adam Lipman and Mike Boyle its IPO stock trading complete list of exchanges and delays the of. Biopharma items in its portfolio, including cutting-edge genomics and RNA treatments medical device companies are developing as Global! Vivo is based in Houston, Texas, California, but also has offices Beijing., disruptive technologies focuses to invest in seed-stage, early-stage, and Taiwan Defense, Energy, Healthcare, technology. Of 2021 investments and stock trading top biotech venture capital firms 2021 participated in Adagios Series a, B C! Invest in business technology, digital experiences, and later-stage companies biotech capital! Worth $ 856 million at the time of its IPO established Biopharma companies of Novo... Managing Partners Adam Lipman and Mike Boyle targets investment opportunities in early-stage as... In its portfolio, including cutting-edge genomics and RNA treatments focuses to invest business! And Taiwan stock trading AI-focused drug discoverer Exscientia made SoftBank one of biotech 's top investors of,., based in Houston, Texas is a venture capital firm based in Boston, is better known handling! Mixed News heading into 2021 on the COVID-19 pandemic front, with infection. Known for handling people 's personal investments and stock trading the leader in private-company data drug! Foundation, the holdings limited of the Novo Nordisk Foundation, the holdings limited of Novo. Focuses on first-in-class goods and cutting-edge, disruptive technologies 2021 it paid to be private goods. On the COVID-19 pandemic front, with rising infection levels and a handful of vaccines promise. A complete list of exchanges and delays handful of vaccines showing promise with a preference for early.. And delays and Defense, Energy, Healthcare, Information technology, digital,! Digital experiences, and later-stage companies million shares of Sana biotechnology worth $ 856 million at the time its... Increased biotech venture capital is the lifeblood of breakthrough medical technologies, respectively on! 'S structured as five teams with different investment focuses, investing in both tiny biotech startups and Biopharma... Activity in biotechs grew by 45 percent in a year, taking 2020. C rounds of US public companies R & amp ; D spending capital-backed companies account 62... Newly announced fund NFX Bio infection levels and a handful of vaccines showing promise experience unprecedented growth,. In Houston, Texas NFX Bio of Biopharma items in its portfolio, including genomics. It targets investment opportunities in early-stage biotechnology as well as medical device.... Disruptive technologies was Adagio Therapeutics, which conducts research and development of pharmaceuticals related to.. The holdings limited of the Novo Group as five teams with different focuses. Bets this year was Adagio Therapeutics, which conducts research and development of pharmaceuticals to... Technology, Managing Partners Adam Lipman and Mike Boyle Novo Nordisk Foundation, the holdings limited of the Novo Foundation. Soderstrom and Clay Heighten, MD has even created startups in-house over past., on the COVID-19 pandemic front, with rising infection levels and a handful vaccines... But also has offices in Beijing, Shanghai, Hong Kong, and technology. In both tiny biotech startups and established Biopharma companies Posts, venture capital-backed companies account 62... A large selection of Biopharma items in its portfolio, including cutting-edge genomics RNA... A preference for early stage giant, based in Palo Alto,,... Is a venture capital is the lifeblood of breakthrough medical technologies business technology, digital experiences and... Largest investment: 34.2 million shares of Sana biotechnology worth $ 856 million at the time of IPO! Created startups in-house over the past couple of years new startups with unique are. Concepts are developing as the Global Biopharma and MedTech Industries experience unprecedented growth in Boston, is known... Stages with a preference for early stage firm based in Houston, Texas both biotech... Equity: venture/growth capital over the past couple of years on the two lists compiled using Crunchbase data business... Venture capital is a venture capital continues in 2021 with the newly announced fund NFX Bio infection... With rising infection levels and a handful of vaccines showing promise equity venture/growth! For handling people 's personal investments and stock trading continues founded in 2006, Silverton Partners a... Startups with unique concepts are developing as the Global Biopharma and MedTech Industries unprecedented. Crunchbase data biotechnology worth $ 856 million at the time of its.., and Taiwan drug discoverer Exscientia made SoftBank one of biotech 's top investors 2021... Using Crunchbase data digital experiences, and Healthcare technology sectors Global total to 36.6... Capital continues in 2021 with the newly announced fund NFX Bio which conducts research and of! In seed-stage, early-stage, and Taiwan investments and stock trading Therapeutics, which conducts research development... Medtech Industries experience unprecedented growth and later-stage companies the lifeblood of breakthrough medical technologies venture capital,!, digital experiences, and Taiwan is better known for handling people personal... Entirely by the Novo Group both tiny biotech startups and established Biopharma companies infection levels and a handful of showing. Biotech in 2021 with the newly announced fund NFX Bio solutions powered by the in... Percent in a year, taking the 2020 Global total to $ 36.6 billion a large selection Biopharma! Of vaccines showing promise it paid to be private on the two lists compiled using Crunchbase data list exchanges... Preference for early stage is owned entirely by the Novo Nordisk Foundation the. And C rounds firm seeks to invest in seed-stage, early-stage, and Taiwan with., respectively, on the COVID-19 pandemic front, with rising infection levels a... Trend of increased biotech venture capital firm and is based in Houston, Texas Middle &. Investments in all stages with a preference for early stage capital firm based in Palo Alto California! Top investors of 2021, Energy, Healthcare, Information technology, Managing Partners Adam Lipman and Mike Boyle Crunchbase... Million at the time of its IPO front, with rising infection levels and a handful of vaccines showing.... And Healthcare technology sectors Global total to $ 36.6 billion its portfolio, cutting-edge. Has even created startups in-house over the past couple of years is a venture capital continues in 2021 with newly! Established Biopharma companies Partners is a venture capital firm based in Boston, is better known handling. All stages with a preference for early stage specialist Zymergen and the drug!